AMERIPRISE FINANCIAL INC - INTEGRA LIFESCIENCES HLDGS C ownership

INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 239 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERIPRISE FINANCIAL INC ownership history of INTEGRA LIFESCIENCES HLDGS C
ValueSharesWeighting
Q3 2023$3,489,956
-8.6%
91,384
-1.6%
0.00%0.0%
Q2 2023$3,818,591
-33.4%
92,842
-7.0%
0.00%
-50.0%
Q1 2023$5,732,159
+0.8%
99,846
-1.5%
0.00%0.0%
Q4 2022$5,687,000
+29.1%
101,407
-2.5%
0.00%0.0%
Q3 2022$4,406,000
-24.9%
104,015
-4.2%
0.00%0.0%
Q2 2022$5,863,000
-17.4%
108,520
-1.8%
0.00%0.0%
Q1 2022$7,101,000
-4.6%
110,492
-0.5%
0.00%0.0%
Q4 2021$7,440,000
-4.0%
111,071
-1.8%
0.00%0.0%
Q3 2021$7,749,000
-7.5%
113,147
-7.8%
0.00%
-33.3%
Q2 2021$8,379,000
-5.8%
122,783
-4.6%
0.00%0.0%
Q1 2021$8,896,000
+4.2%
128,766
-2.1%
0.00%0.0%
Q4 2020$8,538,000
+31.2%
131,533
-4.6%
0.00%0.0%
Q3 2020$6,509,000
-8.3%
137,846
-8.8%
0.00%0.0%
Q2 2020$7,100,000
+4.4%
151,099
-0.8%
0.00%
-25.0%
Q1 2020$6,802,000
-28.9%
152,281
-7.2%
0.00%0.0%
Q4 2019$9,564,000
-10.5%
164,111
-7.7%
0.00%
-20.0%
Q3 2019$10,683,000
+11.8%
177,835
+3.9%
0.01%
+25.0%
Q2 2019$9,555,000
-3.3%
171,090
-3.5%
0.00%
-20.0%
Q1 2019$9,877,000
+21.1%
177,255
-2.0%
0.01%
+25.0%
Q4 2018$8,155,000
-46.8%
180,836
-22.3%
0.00%
-20.0%
Q3 2018$15,324,000
-14.8%
232,631
-16.7%
0.01%
-37.5%
Q2 2018$17,989,000
-23.9%
279,294
-34.6%
0.01%
-27.3%
Q1 2018$23,625,000
+18.1%
426,915
+2.1%
0.01%
+22.2%
Q4 2017$20,009,000
-6.3%
418,067
-1.1%
0.01%
-10.0%
Q3 2017$21,347,000
-10.0%
422,869
-2.8%
0.01%
-16.7%
Q2 2017$23,709,000
+33.1%
434,993
+2.9%
0.01%
+33.3%
Q1 2017$17,812,000
-7.1%
422,781
+89.2%
0.01%
-10.0%
Q4 2016$19,171,000
-9.6%
223,451
-13.0%
0.01%
-16.7%
Q3 2016$21,200,000
+7.4%
256,820
+3.8%
0.01%0.0%
Q2 2016$19,740,000
+18.6%
247,449
+0.1%
0.01%
+20.0%
Q1 2016$16,645,000
-10.5%
247,093
-10.0%
0.01%
-9.1%
Q4 2015$18,606,000
+9.9%
274,504
-3.4%
0.01%
+10.0%
Q3 2015$16,926,000
-17.7%
284,256
-6.9%
0.01%
-16.7%
Q2 2015$20,562,000
+1.5%
305,213
-7.1%
0.01%0.0%
Q1 2015$20,264,000
+6.8%
328,687
-6.1%
0.01%
+9.1%
Q4 2014$18,976,000
+45.2%
349,922
+32.9%
0.01%
+37.5%
Q3 2014$13,068,000
+109.0%
263,248
+98.1%
0.01%
+100.0%
Q2 2014$6,253,000
+5.1%
132,877
+2.7%
0.00%0.0%
Q1 2014$5,951,000
-3.3%
129,387
+0.3%
0.00%0.0%
Q4 2013$6,153,000
+86.2%
128,983
+57.1%
0.00%
+100.0%
Q3 2013$3,304,000
+18.9%
82,089
+8.3%
0.00%0.0%
Q2 2013$2,778,00075,8310.00%
Other shareholders
INTEGRA LIFESCIENCES HLDGS C shareholders Q3 2020
NameSharesValueWeighting ↓
Champlain Investment Partners, LLC 5,473,820$305,001,0002.66%
FALCON POINT CAPITAL, LLC 80,729$4,498,0002.45%
Tributary Capital Management, LLC 508,838$28,352,0002.06%
Broadfin Capital, LLC 141,572$7,888,0001.63%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 182,585$10,174,0001.57%
Sapience Investments, LLC 132,810$7,400,0000.98%
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. 1,110,177$61,860,0000.83%
Bellevue Group AG 222,350$12,389,0000.68%
Capital International Sarl 74,325$4,141,0000.52%
Hood River Capital Management LLC 180,772$10,073,0000.51%
View complete list of INTEGRA LIFESCIENCES HLDGS C shareholders